# Pizarra — PT-pseudo_0de7e606ca70 (task 1)

## [1] CASE FILE

**INTAKE** — *the patient record, verbatim; adds no interpretation*

The structured clinical record below is the read-only panel the urologist sees up front, exactly as it arrives in this patient's record. The documents it refers to are masked and must be retrieved.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_0de7e606ca70
Task: 1

Encounter: Urology - outpatient on 15 Jan 2025.
Referrer: Dr. N. Kuiper (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 65-year-old male
  - PSA: 9.0 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.409 ng/mL²
  - PSA velocity: 1.24 ng/mL/yr
  - Prior PSA: 7.8 ng/mL
  - Prostate volume: 22.03 mL
  - Months since last PSA: 1
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.886139 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Hypertension
  - Problem list / PMHx: Hypertension
  - Current medication: valsartan, lisinopril
  - Allergies: NKA
  - Additional notes: PSA 9 ng/mL. PI-RADS 5. PSAD 0.41. Prostate volume 22 mL. csPCa 0.89.

Vitals: weight 76 kg, height 183 cm, BMI 22.7, BP 138/91 mmHg, HR 78 bpm. Smoking: Ex-smoker (27 pack-yr, quit 2017).

Chief complaint: Clinical attention directed toward steadily climbing PSA values alongside newly acquired mpMRI results.

History: Primary care surveillance has tracked his PSA trajectory for approximately two years. He is a sixty-five-year-old retired truck driver, never married, yet residing with his partner. Daily habits feature a twenty-minute walking regimen and a weekly alcohol intake capped at four units. Chronic hypertension remains stable on valsartan and lisinopril. He also carries a smoking background of 27 pack-years, though cessation occurred in 2017. Lower urinary tract complaints are minimal, scoring a 7 on the IPSS questionnaire, and he has never experienced urinary retention or visible blood in the urine. Outside of urological care, he recently completed a standard hearing evaluation and consulted a pain specialist regarding persistent right shoulder aches. Administrative correspondence and paperwork are handled by his grown daughter, acting with explicit permission.

Physical examination: DRE: A normal prostate presents with symmetrically smooth contours and uniform consistency, devoid of discrete masses or lateral asymmetry. Systemic evaluation shows stable vitals: a blood pressure of 138/91 mmHg and a pulse rate of 78 bpm. Comprehensive review of systems and vital parameters indicates no peripheral adenopathy or skeletal tenderness.

Patient info: retired truck driver; Never married; Lives with partner.
Next of kin: Adult daughter (primary contact).

Lifestyle: alcohol 4 units / week; exercise Walking 20 min/day; IPSS score: 7/35 (mild LUTS).

Recent other appointments: Audiology — hearing test; Pain clinic — chronic shoulder pain.
Admin: Daughter manages communication; CC on letters with patient consent.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


[Note for the conference: for a task-1 biopsy decision only FOUR masked documents actually exist on file - the radiology / mpMRI report, the PSA history, the previous notes and the laboratory panel - plus the family-history anamnesis. There is no pathology report to retrieve for this task; the prior-biopsy status shown in the panel above is all the pathology information on record.]

## [2] INITIAL RECOMMENDATION (statistical prior)

**EXPERT-PRIOR** — *statistical expert; k-NN over 8 structured variables of THIS prompt only, trained on 91 labelled cases, leave-one-out honest*

A basic classifier, whose sole purpose is to provide a suggestion, produces this result along with its associated uncertainty. The purpose of this decision is to use it as an initial reference point for discussing the results.

SUGGESTION: BIOPSY
  p(biopsy = yes) = 0.88 +/- 0.11   (95% CI 0.59-1.00)

Where the uncertainty comes from:
  - aleatoric  dA = 0.10  (the nearest labelled cases disagree with each other)
  - epistemic  dA = 0.05  (few labelled cases resemble this one)
  - 8.3 effective neighbours out of 10; 5 of the 5 closest labelled cases were biopsied
  - 80%-coverage conformal set: {yes}

TIER 'firm': A +/- 1.96*dA does not cross the 0.5 threshold. On the 91 labelled cases this tier was never wrong, but it only covered 17 of them, so the 95% CI on that accuracy still reaches down to ~0.75. Treat it as a strong prior that should only be overturned by explicit contradicting evidence.

Variables it actually read (from the visible panel only, no documents retrieved):
  pirads=5.0, bx_ord=0.0, psa=9.0, age=65.0, psad=0.409, dre_ord=0.0, vol=22.03, n_pmhx=1.0
  missing / not evaluable: none

Out-of-fold performance of this recommender on the 91 labelled cases (5x5 CV):
  accuracy 0.703, balanced accuracy 0.662, AUC 0.75, ECE 0.095.
It is right about 7 times out of 10 overall. It is NOT an oracle and it has never seen the
radiology report, the PSA trajectory, the laboratory panel or the previous notes.

## [3] GAPS AND DOUBTS

**LLM-1-GAP-ANALYST** — *raises doubt only; has no access to clinical documents and issues no recommendation*

WHAT THE PRIOR CANNOT SEE
  The statistical recommender relied only on the structured panel. It could not weigh the patient's PSA velocity (1.24 ng/mL/yr) or the full PSA history trend, which is crucial for assessing the rate of change, against the high PI-RADS score (5) and high csPCa probability (0.886139). It also missed the context provided by the mpMRI report prose, which is essential for interpreting the PI-RADS 5, and the specific details from the laboratory panel.

WHY THE SUGGESTION COULD BE WRONG
  The prior suggests biopsy (0.88), but the uncertainty is high (error bar $\pm 0.11$). A failure mode is the high csPCa probability (0.886139) combined with a normal DRE, which might suggest a lower threshold for biopsy than the prior assumes. Another failure mode is the lack of information regarding the PSA velocity trend; a rapidly rising PSA might warrant a different approach than a stable one, which the prior cannot assess.

WHAT TO RETRIEVE, AND WHAT WOULD CHANGE THE ANSWER
  <document> -> radiology / mpMRI report -> If the prose suggests a low-risk feature despite PI-RADS 5, it would decrease the likelihood of biopsy.
  <document> -> PSA history (trend) -> If the trend is flat or declining despite the high current PSA, it would decrease the likelihood of biopsy.
  <document> -> laboratory results (full panel) -> If specific markers (e.g., PSA density) contradict the risk profile, it would alter the decision.
  <document> -> previous GP / urology consultation notes -> If prior notes mention specific LUTS or other findings that modify the clinical picture, it would refine the decision.

## [4] EVIDENCE REPORT

**LLM-2-EVIDENCE** — *the only participant who retrieved documents; reports findings, not verdicts*

RETRIEVED
  One block per document you opened. Quote the values and phrases that matter, verbatim and with units. Numbers, lesion descriptions, dates, explicit radiologist or clinician recommendations. Do not paraphrase a number. If a document turned out to be uninformative, say so in one line - that is an honest result.

  **radiology / mpMRI report**
  Subject: Prostate mpMRI / Facility: Catharina Ziekenhuis, Eindhoven / Date: 12 January 2025

  Clinical indication: Assessment of a PSA value of 9.0 alongside clinical concerns for malignancy.

  FINDINGS:
  Prostate volume registers at 22.03 mL. T2 sequences highlight a discrete hypointense focus in the right peripheral zone, spanning the base to mid gland, with a maximum diameter near 14 mm. Diffusion-weighted imaging shows marked restriction, mirrored by a corresponding drop on the ADC map. Contrast kinetics demonstrate prompt, pronounced focal uptake against background tissue. The capsule remains intact without seminal vesicle involvement, and pelvic nodes appear normal.

  IMPRESSION:
  PI-RADS 5 lesion located in the right peripheral zone.
  Prostate volume 22.03 mL, PSA density 0.409 ng/mL/mL.
  csPCa predicted probability 0.886139.

  **PSA history**
  {"case_id": "PT-pseudo_0de7e606ca70", "psa_trend": [{"date": "Aug 2023", "val": 3.3}, {"date": "Feb 2024", "val": 4.6}, {"date": "Jul 2024", "val": 6.4}, {"date": "Jan 2025", "val": 9.0}]}

  **laboratory results**
  {"name": "PSA", "val": "9.0 ng/mL", "date": "20 Dec 2024", "flag": "H"}, {"name": "Free PSA", "val": "2.18 ng/mL", "date": "20 Dec 2024", "flag": ""}, {"name": "%Free PSA", "val": "24%", "date": "20 Dec 2024", "flag": ""}, {"name": "Haemoglobin", "val": "15.4 g/dL", "date": "20 Dec 2024", "flag": ""}, {"name": "WBC", "val": "5.6 x10^9/L", "date": "20 Dec 2024", "flag": ""}, {"name": "Platelets", "val": "199 x10^9/L", "date": "20 Dec 2024", "flag": ""}, {"name": "Creatinine", "val": "86 umol/L", "date": "20 Dec 2024", "flag": ""}, {"name": "eGFR", "val": ">60 mL/min/1.73m2", "date": "20 Dec 2024", "flag": ""}, {"name": "Testosterone", "val": "17.9 nmol/L", "date": "20 Dec 2024", "flag": ""}, {"name": "Alkaline phosphatase", "val": "83 U/L", "date": "20 Dec 2024", "flag": ""}, {"name": "LDH", "val": "206 U/L", "date": "20 Dec 2024", "flag": ""}, {"name": "HbA1c", "val": "6.2 %", "date": "20 Dec 2024", "flag": ""}}

  **previous GP / urology consultation notes**
  {"date": "20 May 2024", "author": "Dr. N. Kuiper (GP)", "text": "Subsequent clinic visit focused on ongoing PSA elevation. A February 2024 draw showed a level of 7.6 ng/mL, continuing a consistent climb from earlier baselines. This trajectory prompted transfer to urology for specialized evaluation and further imaging. Standard laboratory panels fell within expected ranges for his demographic."}, {"date": "25 Jul 2023", "author": "Dr. N. Kuiper (GP)", "text": "Cardiovascular assessment paired with prostate cancer screening metrics. An initial PSA reading of 6.2 ng/mL triggered a confirmatory August draw, which mirrored that elevation. No acute urological complaints were noted during this encounter."}

NOT RETRIEVED
  get_family_history - Not called as per retrieval economy rules.

WHAT THE EVIDENCE SUPPORTS
  FOR sampling this patient now:
  PI-RADS 5 lesion located in the right peripheral zone
  PSA velocity of 1.24 ng/mL/yr (based on current vs prior)
  PSA trend shows a consistent climb (3.3 -> 4.6 -> 6.4 -> 9.0 ng/mL)
  csPCa predicted probability 0.886139

  AGAINST sampling this patient now:
  DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)

WHERE THIS LEANS
  The evidence strongly points toward sampling due to the high-risk MRI finding (PI-RADS 5), the significant PSA velocity, and the rising PSA trend, which aligns with the statistical prior. This evidence strongly supports the initial suggestion of biopsy.

[Sections actually revealed in this consultation: psa_trend, radiology_report, laboratory_results, previous_notes. Tools executed: get_lab_results, get_mri_report, get_previous_notes, get_psa_trend.]

## [5] IMAGE-EMBEDDING PREDICTOR

**EXPERT-IMAGE** — *image-embedding expert; frozen foundation-model MRI vectors behind a trained head*

Frozen foundation-model embeddings on file for this patient: MRI image (1 vector).
The raw vectors are never shown; only a compact score would be.

No calibrated head is deployed for the biopsy decision, so no score was produced. The probe that measured this modality for task 1 reported AUC 0.43 (at or below chance), which is why nothing is being asserted here.

Bottom line for the chair: the image-embedding route contributes NO usable evidence for this
biopsy decision. Decide on the structured panel, the retrieved documents and the guidelines.
Do not cite imaging-embedding support in the reasoning, and do not let the absence of a score
count as a negative finding.

## [6] FINAL DECISION AND FORM

**LLM-3-CHAIR** — *chairs the conference; the only participant who decides*

FINAL DECISION: BIOPSY   (confidence: clear)

Biopsy is recommended due to the convergence of high-risk findings: a PI-RADS 5 lesion, a significant PSA velocity of 1.24 ng/mL/yr, and a clear, consistent upward trend in PSA from 3.3 ng/mL to 9.0 ng/mL over two years. The statistical prior suggested biopsy, and the retrieved evidence strongly supports this by highlighting the high-risk imaging and dynamic biochemical changes.

Variables that carried weight: age=noted, psa=decisive, vol=noted, psad=important, pirads=decisive, comorbidity=noted
Sections revealed: psa_trend, radiology_report, laboratory_results, previous_notes
